Prevention trial for Coronary Artery Disease
Official title AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
ClinicalTrials.gov ID: NCT06235112
What this study is testing
- What it's testing
- The study wants to see if showing doctors the amount of calcium in the heart arteries from a chest CT will lead them to start or increase preventive treatments.
- Who it's for
- Adults who have coronary artery disease or are at risk and are getting a chest CT scan.
- What's involved
- Participants will have a non‑contrast chest CT scan. An AI platform will analyze the scan for calcium and report the score to the treating doctor, who may then adjust medications or other preventive measures.
- Time commitment
- The study lasts until the next scheduled visit after the CT scan, typically a few weeks, with the required CT scan and any follow‑up visits.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 75
You may be able to join if
- Patients aged between 40-75 with prior chest CT within last 3 years
You likely can't join if
- Prior coronary artery disease
- Prior cancer
- Other life-limiting condition
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.